Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

Detalles Bibliográficos
Autores principales: Váraljai, Renáta, Zimmer, Lisa, Al-Matary, Yahya, Kaptein, Paulien, Albrecht, Lea J., Shannan, Batool, Brase, Jan C., Gusenleitner, Daniel, Amaral, Teresa, Wyss, Nina, Utikal, Jochen, Flatz, Lukas, Rambow, Florian, Reinhardt, Hans Christian, Dick, Jenny, Engel, Daniel R., Horn, Susanne, Ugurel, Selma, Sondermann, Wiebke, Livingstone, Elisabeth, Sucker, Antje, Paschen, Annette, Zhao, Fang, Placke, Jan M., Klose, Jasmin M., Fendler, Wolfgang P., Thommen, Daniela S., Helfrich, Iris, Schadendorf, Dirk, Roesch, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518252/
https://www.ncbi.nlm.nih.gov/pubmed/37580519
http://dx.doi.org/10.1038/s43018-023-00632-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518252/
https://www.ncbi.nlm.nih.gov/pubmed/37580519
http://dx.doi.org/10.1038/s43018-023-00632-w

Ejemplares similares